Cargando…

Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?

BACKGROUND: Decisions about asymptomatic COVID-19 patients are always critical, either during initial screening or during recovery. Spread of infection will be inevitable if those patients were left non-isolated. This study aimed not only to survey spectrum of HRCT findings of COVID-19 among asympto...

Descripción completa

Detalles Bibliográficos
Autores principales: Samir, Ahmed, Abdelgawad, Mohamed Saied, Baess, Ayman Ibrahim, Hassan, Hebatallah Hassan Mamdouh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705406/
http://dx.doi.org/10.1186/s43055-020-00356-2
_version_ 1783616949471674368
author Samir, Ahmed
Abdelgawad, Mohamed Saied
Baess, Ayman Ibrahim
Hassan, Hebatallah Hassan Mamdouh
author_facet Samir, Ahmed
Abdelgawad, Mohamed Saied
Baess, Ayman Ibrahim
Hassan, Hebatallah Hassan Mamdouh
author_sort Samir, Ahmed
collection PubMed
description BACKGROUND: Decisions about asymptomatic COVID-19 patients are always critical, either during initial screening or during recovery. Spread of infection will be inevitable if those patients were left non-isolated. This study aimed not only to survey spectrum of HRCT findings of COVID-19 among asymptomatic and recovered patients but also to record unexpected results and document their impact upon the clinical decision. RESULTS: The study was retrospectively conducted, during June and July 2020, on 120 patients proved with COVID-19, during initial HRCT screening or delayed following announcement of recovery. All patients were completely asymptomatic. They included 72 males and 48 females (60%:40%). Their age ranged from 10 to 58 years (mean 35.95 ± 12.25 SD). HRCT was analyzed by three expert consultant radiologists in consensus. Among asymptomatic initially screened COVID-19 patients, additional to GGOs, bilateral consolidative changes were unexpectedly found together with secondary fibrosis (23.3% and 10%). HRCT results significantly impacted the clinical decision (P < 0.0001); PCR had to be repeated with home isolation (43.3%). Infected health care providers had to stop their duty immediately (20%). Isolated hospitalization replaced routine ward admission (25%). Cautious surgical interference was performed using full personal protective equipment (PPE) (8.3%). Among asymptomatic recovered COVID-19 patients, unexpected large lesions (> 3 cm) were found (70%). Near 50% of lung volume was persistently affected (10%). Secondary fibrosis was striking (33%). Encysted hydro-pneumothorax persisted for a whole month (1.7%). “No-isolation” decision remained unchanged because of clinical and laboratory stability; however, steroids were prescribed to speed lung recovery. CONCLUSION: HRCT findings among asymptomatic and recovered COVID-19 patients can be unexpected and can definitely impact the clinical decision.
format Online
Article
Text
id pubmed-7705406
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-77054062020-12-01 Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision? Samir, Ahmed Abdelgawad, Mohamed Saied Baess, Ayman Ibrahim Hassan, Hebatallah Hassan Mamdouh Egypt J Radiol Nucl Med Research BACKGROUND: Decisions about asymptomatic COVID-19 patients are always critical, either during initial screening or during recovery. Spread of infection will be inevitable if those patients were left non-isolated. This study aimed not only to survey spectrum of HRCT findings of COVID-19 among asymptomatic and recovered patients but also to record unexpected results and document their impact upon the clinical decision. RESULTS: The study was retrospectively conducted, during June and July 2020, on 120 patients proved with COVID-19, during initial HRCT screening or delayed following announcement of recovery. All patients were completely asymptomatic. They included 72 males and 48 females (60%:40%). Their age ranged from 10 to 58 years (mean 35.95 ± 12.25 SD). HRCT was analyzed by three expert consultant radiologists in consensus. Among asymptomatic initially screened COVID-19 patients, additional to GGOs, bilateral consolidative changes were unexpectedly found together with secondary fibrosis (23.3% and 10%). HRCT results significantly impacted the clinical decision (P < 0.0001); PCR had to be repeated with home isolation (43.3%). Infected health care providers had to stop their duty immediately (20%). Isolated hospitalization replaced routine ward admission (25%). Cautious surgical interference was performed using full personal protective equipment (PPE) (8.3%). Among asymptomatic recovered COVID-19 patients, unexpected large lesions (> 3 cm) were found (70%). Near 50% of lung volume was persistently affected (10%). Secondary fibrosis was striking (33%). Encysted hydro-pneumothorax persisted for a whole month (1.7%). “No-isolation” decision remained unchanged because of clinical and laboratory stability; however, steroids were prescribed to speed lung recovery. CONCLUSION: HRCT findings among asymptomatic and recovered COVID-19 patients can be unexpected and can definitely impact the clinical decision. Springer Berlin Heidelberg 2020-12-01 2020 /pmc/articles/PMC7705406/ http://dx.doi.org/10.1186/s43055-020-00356-2 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Research
Samir, Ahmed
Abdelgawad, Mohamed Saied
Baess, Ayman Ibrahim
Hassan, Hebatallah Hassan Mamdouh
Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
title Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
title_full Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
title_fullStr Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
title_full_unstemmed Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
title_short Spectrum of HRCT findings among asymptomatic and recovered COVID-19 patients: how did they impact the clinical decision?
title_sort spectrum of hrct findings among asymptomatic and recovered covid-19 patients: how did they impact the clinical decision?
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705406/
http://dx.doi.org/10.1186/s43055-020-00356-2
work_keys_str_mv AT samirahmed spectrumofhrctfindingsamongasymptomaticandrecoveredcovid19patientshowdidtheyimpacttheclinicaldecision
AT abdelgawadmohamedsaied spectrumofhrctfindingsamongasymptomaticandrecoveredcovid19patientshowdidtheyimpacttheclinicaldecision
AT baessaymanibrahim spectrumofhrctfindingsamongasymptomaticandrecoveredcovid19patientshowdidtheyimpacttheclinicaldecision
AT hassanhebatallahhassanmamdouh spectrumofhrctfindingsamongasymptomaticandrecoveredcovid19patientshowdidtheyimpacttheclinicaldecision